Chronic Myelomonocytic Leukemia Clinical Trials in Cleveland, Ohio

3 studies are recruiting for chronic myelomonocytic leukemia in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

    This phase II trial studies the side effects and how well azacitidine and enasidenib work in treating patients with IDH2-mutant myelodysplastic syndrome. Azacitidine and enasidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

    Stage
    Phase 2
    Ages
    12 and older
    Site
    Cleveland Clinic Foundation, Cleveland, Ohio
    Locations
    3 in total
    Run by
    M.D. Anderson Cancer Center

    See if you can join NCT03383575 on ClinicalTrials.gov

  2. Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

    This phase I trial tests the safety, side effects, and effectiveness of olutasidenib in preventing the return of disease (relapse) in patients who have undergone donor (allogeneic) hematopoietic cell transplant for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocy…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Cleveland Clinic Cancer Center, Cleveland, Ohio
    Locations
    2 in total
    Run by
    City of Hope Medical Center

    See if you can join NCT06543381 on ClinicalTrials.gov

  3. Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

    The main purpose of this study is to identify a safe and potentially effective dose of tuspetinib to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic syndromes with increased blasts grade 2 (MDS-IB2), or chronic myelomonocytic leukemia (CM…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio
    Locations
    34 in total
    Run by
    Aptose Biosciences Inc.

    See if you can join NCT03850574 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.